Betty Neuman Systems Model

The study tested the application of the Betty Neuman’s Systems Model (Model) which dealt with assessment and also the study was used to determine what followed chemotherapy-induced nausea and vomiting in patients diagnosed with breast cancer receiving doxorubicin-based chemotherapy. Depending on the client's ability to handle the environmental stressors, the client can have either a positive or a negative outcome. Several patients with breast cancer receive chemo- therapy after surgery to substantially decrease the threat of relapse, and generally are accompanied by prescriptions of doxorubicin and cyclophosphamide. According to the article, chemotherapy-induced nausea and vomiting continues to be substantial and disturbing side effects
Secondary prevention can take place during treatment, when the symptoms can be identified and treated with additional medications or prevention education materials. Tertiary prevention is achieved by building on the client's strengths and conserving energy. Tertiary prevention should aim to reeducate the client about the importance of CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
For example, determining which of the five variables contribute to the development of severe CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING for the client will allow nurses to determine which client is more likely to experience severe nausea and vomiting, provide anticipatory guidance for clients, and individualize treatment with anti-nausea medications.
Another case in point is a descriptive study done using The Betty Neuman’s Systems Model whose purpose was to pilot a questionnaire with sub-scales in a population of 40 family members listed as power of attorney (POA) for residents and 40 employees of a long term care facility in rural southeastern Kansas. There were 49 non-random participants which resulted in a 61.25% participation